 |
|
|
| |
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention Among Women Who Engaged in Transactional Sex
|
| |
| |
IAS 2021 July 18-22
Erica N Browne1, Kristine Torjesen2, Brenda Gati Mirembe3, Thesla Palanee- Phillips4, Nitesha Jeenarain5, Miria Chitukuta6, Leila Mansoor7, Krishnaveni Reddy4, Thelma Tauya6, Logashvari Naidoo5, Samantha Siva5, Barbra Richardson8, Bonus Makanani9, Lydia Soto-Torres10, Ariane van der Straten1,11 on behalf of the MTN-020/ASPIRE Study Team
1Women's Global Health Imperative, RTI International, Berkeley, CA, USA; 2FHI 360, Durham, NC, USA; 3Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda; 4Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa; 5South African Medical Research Council, Durban, South Africa; 6University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe; 7Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; 8Department of Biostatistics, University of Washington, Seattle, WA, USA; 9College of Medicine-John Hopkins University Research Project, Blantyre, Malawi; 10Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Mental Health, and Eunice Shriver Kennedy, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA; 11 University of California San Francisco, San Francisco, CA, USA
|
| |
|
|
|
|
|
